Patient centred choice of anti-thyroid drugs in the treatment of graves' disease.

Antithyroid drugs (ATDs) are the mainstay of management of Graves' disease. While the choice of therapeutic modality namely anti-thyroid drugs, surgery and radio iodine ablation, has been studied in detail, less attention has been paid to the factors that influence choice of anti-thyroid medication. This article describes a patient centred approach to this challenge. The authors also describe the biomedical and psychosocial factors which may influence the choice of therapy.